Ad
related to: treatment for severe covid-19
Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoInsmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis PR Newswire BRIDGEWATER, N.J., May 28, 2024 —Phase 3 Study Achieves Primary Endpoint for Both Dosage Strengths of Brensocatib with
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 3 days agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
‘Seek care immediately’: Four dead in outbreak of waterborne disease following Brazil floods
The Telegraph via Yahoo News· 3 days agoMore than 50 cases of the waterborne leptospirosis disease have been confirmed in the wake of...
1 in 9 US children now have ADHD, with surge in diagnoses since 2016: CDC
ABC News· 4 days agoDiagnoses of children with attention-deficit/hyperactivity disorder (ADHD) have surged in the United...
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
WPRI Providence· 4 days agoHighlights: Statistically significant improvement from baseline assessed by both clinicians and caregivers in all four efficacy measures specifically designed for Pitt Hopkins syndrome (Wilcoxon ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 hours agoThe US Food and Drug Administration (FDA) has extended by three months the target action date of its priority review of the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab ...
With avian flu and a new coronavirus variant spreading as summer begins, how can we keep healthy and...
CNN.com· 4 days agoMemorial Day is here, and soon summer will arrive. The threat of some diseases, such as Covid-19 is...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 hours agoThe European Commission is expected to announce a final decision on the Dupixent application in the coming months.
Teen Cannabis Use Tied to Dramatic Increased Psychosis Risk
Medscape· 15 hours agoAdolescents who use cannabis have a dramatically increased risk for psychosis, making evidence-based...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 2 days agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
